-
公开(公告)号:US20240352056A1
公开(公告)日:2024-10-24
申请号:US18687856
申请日:2022-09-06
IPC分类号: C07H19/213 , C07H1/02
CPC分类号: C07H19/213 , C07H1/02
摘要: The present invention relates to a method for preparing cyclic guanosine-3′, 5′-monophosphate analogues. The invention also relates to the new cyclic guanosine-monophosphate analogues and intermediates obtained by the method.
-
公开(公告)号:US20240299431A1
公开(公告)日:2024-09-12
申请号:US18575462
申请日:2022-07-19
发明人: Francesco PERI , Alessio ROMERO , Simona D'AMATO
摘要: The present invention relates to new synthetic molecules with agonist activity of human Toll-like Receptor 4 (TLR4), compositions comprising them and uses thereof for the treatment of diseases in which it is useful to induce or increase an immune response. These new syntethic molecules differ from other similar agonists due to the simplicity of the formula, the ease and cheapness of preparation and the possibility of further chemical processing to modify the physicochemical properties and allow conjugation to other molecules (for example protein antigens).
-
公开(公告)号:US20220402962A1
公开(公告)日:2022-12-22
申请号:US17888312
申请日:2022-08-15
申请人: NuCana plc
IPC分类号: C07H19/207 , C07H1/02 , C07H19/10 , C07H19/20
摘要: The present invention is a process for the preparation of certain 5′-phosphoramidate nucleotide diastereoisomers. The phosphoramidates include those useful in the treatment of cancer such as NUC-3373 (5-fluoro-2′-deoxyuridine-5′-O-[1-naphthyl(benzyloxy-L-alaninyl)]phosphate].
-
公开(公告)号:US10118941B2
公开(公告)日:2018-11-06
申请号:US15511096
申请日:2015-09-11
申请人: MEDIVIR AB
发明人: Pedro Pinho , Staffan Torssell
摘要: Methods for the preparation of diastereomerically pure phosphoramidate prodrugs of nucleosides, and intermediates useful for the preparation are provided. The nucleosides are useful for the treatment of hepatitis C and cancer.
-
公开(公告)号:US20180311263A1
公开(公告)日:2018-11-01
申请号:US15902690
申请日:2018-02-22
发明人: Byoung Kwon Chun , Michael O' Neil Hanrahan Clarke , Edward Doerffler , Hon Chung Hui , Robert Jordan , Richard L. Mackman , Jay P. Parrish , Adrian S. Ray , Dustin Siegel
IPC分类号: A61K31/685 , A61K31/53 , A61K31/00 , A61K31/6615 , A61K31/665 , A61K31/683 , C07D487/04 , C07H15/18 , C07H11/00 , C07H1/02 , C07H1/00 , A61K45/06 , A61K31/675 , C07F9/6561 , C07F9/24 , C07D519/00
CPC分类号: A61K31/685 , A61K31/00 , A61K31/53 , A61K31/6615 , A61K31/665 , A61K31/675 , A61K31/683 , A61K31/7056 , A61K31/706 , A61K45/06 , C07D487/04 , C07D519/00 , C07F9/2429 , C07F9/65616 , C07H1/00 , C07H1/02 , C07H11/00 , C07H15/18 , A61K2300/00
摘要: Provided are compounds, methods, and pharmaceutical compositions for treating Filoviridae virus infections by administering ribosides, riboside phosphates and prodrugs thereof, of Formula IV: The compounds, compositions, and methods provided are particularly useful for the treatment of Marburg virus, Ebola virus and Cueva virus infections.
-
6.
公开(公告)号:US20180118776A1
公开(公告)日:2018-05-03
申请号:US15560862
申请日:2016-03-25
发明人: Giuseppe BARRECA , Marcello RASPARINI , Andrea POGGIALI , Luca CARCONE , Roberto Rocco TUFARO , Giovanni MARRAS , Maurizio TADDEI , Elena CINI
摘要: Two processes are described for preparing, in different diastereomeric purity degrees, the compound (S)-isopropyl-2-(((S)-(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy)(phenoxy)-phosphoryl)amino) propanoate, having the formula given below, known as Sofosbuvir and used for the treatment of hepatitis C.
-
公开(公告)号:US20170275322A1
公开(公告)日:2017-09-28
申请号:US15511096
申请日:2015-09-11
申请人: MEDIVIR AB
发明人: Pedro PINHO , Staffan TORSSELL
摘要: Methods for the preparation of diastereomerically pure phosphoramidate prodrugs of nucleosides, and intermediates useful for the preparation are provided. The nucleosides are useful for the treatment of hepatitis C and cancer.
-
公开(公告)号:US09724360B2
公开(公告)日:2017-08-08
申请号:US14926062
申请日:2015-10-29
发明人: Byoung Kwon Chun , Michael O' Neil Hanrahan Clarke , Edward Doerffler , Hon Chung Hui , Robert Jordan , Richard L. Mackman , Jay P. Parrish , Adrian S. Ray , Dustin Siegel
IPC分类号: C07H15/18 , C07H7/06 , A61K31/685 , C07D487/04 , C07D519/00 , C07F9/24 , C07F9/6561 , A61K31/675 , A61K45/06 , A61K31/00 , A61K31/53 , C07H1/00 , C07H1/02 , C07H11/00
CPC分类号: A61K31/685 , A61K31/00 , A61K31/53 , A61K31/6615 , A61K31/665 , A61K31/675 , A61K31/683 , A61K45/06 , C07D487/04 , C07D519/00 , C07F9/2429 , C07F9/65616 , C07H1/00 , C07H1/02 , C07H11/00 , C07H15/18 , A61K2300/00
摘要: Provided are compounds, methods, and pharmaceutical compositions for treating Filoviridae virus infections by administering ribosides, riboside phosphates and prodrugs thereof, of Formula IV: The compounds, compositions, and methods provided are particularly useful for the treatment of Marburg virus, Ebola virus and Cueva virus infections.
-
公开(公告)号:US07164015B2
公开(公告)日:2007-01-16
申请号:US10788825
申请日:2004-02-27
申请人: Lifen Shen , San Kiang , Zhenrong Guo
发明人: Lifen Shen , San Kiang , Zhenrong Guo
CPC分类号: C07D309/10 , C07H1/00 , C07H7/04
摘要: The present invention provides a method for making glycoside compounds including the steps of: (a) lithiating an aromatic reactant having a leaving group using a lithium reagent in a first microreactor under non-cryogenic conditions to form a lithiated anion species, and (b) coupling the lithiated anion species with a carbonyl substituted reactant to form a glycoside.
摘要翻译: 本发明提供一种制备糖苷化合物的方法,包括以下步骤:(a)在非低温条件下,在第一微反应器中使用锂试剂锂化具有离去基团的芳族反应物以形成锂化阴离子物质,和(b) 将锂化阴离子物质与羰基取代的反应物偶联以形成糖苷。
-
10.
公开(公告)号:US06114309A
公开(公告)日:2000-09-05
申请号:US975229
申请日:1997-11-21
申请人: Nigel Mark Allanson , Tin Yau Chan , Nicole T. Hatzenbuhler , Rakesh K. Jain , Ramesh Kakarla , Rui Liang , Dashan Liu , Domingos J. Silva , Michael J. Sofia
发明人: Nigel Mark Allanson , Tin Yau Chan , Nicole T. Hatzenbuhler , Rakesh K. Jain , Ramesh Kakarla , Rui Liang , Dashan Liu , Domingos J. Silva , Michael J. Sofia
IPC分类号: C12Q1/02 , A61K31/7016 , A61K31/702 , A61P31/04 , C07B61/00 , C07H1/02 , C07H5/08 , C07H11/04 , C07H15/04 , C07H15/203 , A61K31/70 , C07H13/00
CPC分类号: C07H15/04 , C07H15/203 , C40B40/00
摘要: A combinatorial chemical library of compounds structurally related to the moenomycin class of antibiotics has the formula ##STR1## wherein D is a donor mono- or disaccharide, A is an acceptor monosaccharide, and P-R is a lipophosphoglycerate mimetic group. Members of the library have a glycosidic linkage between the anomeric carbon of D and the C2 carbon of A, and the D-A moiety is in turn covalently linked through the anomeric carbon of A to the P-R group. Members of the library exhibit their greatest structural diversity in terms of substitutions occurring at the C3 position of the A residue, substitutions at the C2 position of the D residue, and different P-R groups used in assembling the compounds. Members of the library are preferably synthesized by solid phase techniques involving stepwise coupling of the respective units to a support, functionalizing the A and/or D saccharides either before or after immobilizing them on the support, and cleaving the assembled compounds from the support. Preferred functionalities attached to the sugar residues are amides, carbamates, ureas, sulfonamides, substituted amines, esters, carbonates, and sulfates. Exemplary P-R groups are derivatives of homoserine, glyceric acid, salicylates and mandelic acid. Members of the library can be screened for anti-microbial activity by contacting them with a culture of microbes and monitoring the growth rate of the microbes.
摘要翻译: 结构上与新霉素类抗生素相关的化合物的组合化学文库具有下式:其中D是供体单糖或二糖,A是受体单糖,P-R是脂磷酸甘油酸酯模拟组。 文库成员在D的异头碳和A的C2碳之间具有糖苷键,D-A部分又通过A的端基异碳共价连接到P-R基团。 关于在A残基的C3位置发生的取代,在D残基的C2位置的取代以及用于组装化合物的不同的P-R基团,图书馆的成员表现出最大的结构多样性。 文库的成员优选通过固相技术合成,其包括将各单元逐步偶联到载体上,在将它们固定在载体上之前或之后将A和/或D糖功能化,并将载体化合物从载体上分离。 附着于糖残基的优选功能是酰胺,氨基甲酸酯,脲,磺酰胺,取代的胺,酯,碳酸酯和硫酸酯。 示例性的P-R基团是高丝氨酸,甘油酸,水杨酸盐和扁桃酸的衍生物。 通过与微生物培养物接触并监测微生物的生长速率,可以筛选图书馆成员的抗菌活性。
-
-
-
-
-
-
-
-
-